Form 4 for AURA Aura Biosciences, Inc.
Accepted 2024-10-16 00:00:00 ET · period of report 2024-10-16 · accession 0000950170-24-115150 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-16 | 2024-10-16 | AURA | Plavsic Mark | CTO | S - Sale | $9.85 | -7,383 | 121.1K | -6% | -$72.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-16 | S | D | 7,383 | $9.85 | 121,132 | D | — | — |